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A variety of evidence suggests that, among humans, the individual tendency to choose immediate rewards (“Now”) over larger, delayed
rewards (“Later”), or Now bias, varies with frontal dopamine (DA) levels. As cyclic elevations in estradiol (E) modulate other frontal
DA-dependent behaviors, we tested ovarian cycle effects on Now bias, and whether any such effects are E mediated. To do so, we
quantified Now/Later choice behavior in naturally cycling adult females (n  87; ages 18 – 40 years) during both the menstrual phase (MP;
cycle day 1–2; low E), and the follicular phase (FP; cycle day 11–12; high E). Now bias decreased an average of 3.6% from MP to FP (p 
0.006). Measures of salivary E levels at each visit were available in a subsample of participants (n  34). Participants with a verified E
rise from MP to FP showed significantly greater decreases in Now bias at mid-cycle (n  23) than those without a rise (n  11; p  0.03);
Now bias decreased an average of 10.2% in the E rise group but increased an average of 7.9% in the no E rise group. The change in Now
bias from MP to FP inversely correlated with the change in E (  0.39; p  0.023), an effect driven by individuals with putatively
lower frontal DA based on genotype at the Val158Met polymorphism in the COMT gene. This is the first demonstration that intertemporal
choice varies across the ovarian cycle, with Now bias declining at mid-cycle, when fertility peaks. Moreover, our data suggest that the
interacting effects of estradiol and frontal DA mediate this cycle effect on decision making.
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Introduction
All animals, including humans, discount delayed rewards (Ma-
zur, 1987; Rachlin, 2000), a tendency variously known as delay
discounting (DD) or temporal discounting. While some degree
of DD is normal, an excessive bias toward selecting immediate
over larger delayed rewards, or “Now bias,” is associated with
multiple clinical conditions, including substance abuse (Becker
and Murphy, 1988; Reynolds, 2006; Perry and Carroll, 2008; Rog-
ers et al., 2010), attention deficit hyperactivity disorder (Barkley
et al., 2001; Sonuga-Barke et al., 2008; Paloyelis et al., 2010), and
pathological gambling (Alessi and Petry, 2003; Leeman and Po-
tenza, 2012). Thus, understanding the biological bases of such
Now bias may have wide-reaching impact. Evidence from both
humans and animals indicates that the individual DD tendency is
heritable (Anokhin et al., 2011; Mitchell, 2011). However, animal
studies also indicate that Now bias can be pharmacologically
modulated, particularly by dopamine (DA; Dalley et al., 2008;
Doya, 2008; Winstanley, 2011).
Accumulating evidence in humans also suggests that DA is a
key regulator of Now bias. First, genetic variations in the DA
system are associated with individual differences in Now bias
(Boettiger et al., 2007; Eisenberg et al., 2007; Paloyelis et al., 2010;
Smith and Boettiger, 2012), particularly variations in the gene
encoding the catechol-O-methyltransferase (COMT) enzyme,
which regulates tonic frontal DA (Karoum et al., 1994; Gogos et
al., 1998; Slifstein et al., 2008; Käenmäki et al., 2010; Wu et al.,
2012); putative lower tonic frontal DA is associated with greater
Now bias among adults (Boettiger et al., 2007; Smith and Boetti-
ger, 2012). Second, human pharmacology studies suggest that
DA modulates Now bias, albeit with inconsistent results (de Wit
et al., 2002; Acheson and de Wit, 2008; Hamidovic et al., 2008; de
Wit, 2009; Pine et al., 2010), although these studies have not
accounted for intrinsic variations in DA signaling that could in-
teract with pharmacological effects. For example, we recently
found that genetic variation in COMT modulates the effect of an
acute DA manipulation of Now bias (Kelm and Boettiger, 2013).
Recent data showing that COMT genotype interacts with cyclic
estradiol (E) changes to affect working memory (Jacobs and
D’Esposito, 2011), which is also frontal DA dependent, suggests
that cyclic variation in E could also modulate Now bias.
Data showing less DD among females relative to males
(Bobova et al., 2009; Peper et al., 2013) support this idea, but no
studies have investigated whether cyclic E fluctuations are as-
sociated with changes in Now bias. We hypothesized that if E
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modulates Now bias, naturally cycling females should demon-
strate reduced Now bias from the menstrual phase (MP) to the
follicular phase (FP). Moreover, such cycle effects should be
modulated by COMT genotype. To test these ideas, we measured
Now bias in a DD task among naturally cycling females (ages
18 – 40 years), during both the MP (cycle days 1–2; putative low
E) and the FP (cycle days 11–12; putative high E). We also
determined the COMT genotype of each subject and were able to
measure free salivary E levels during each visit from a subset of
participants.
Materials and Methods
Sample characteristics. Participants (n  91) were recruited from The
University of North Carolina at Chapel Hill (UNC) and the surrounding
community. Participants were healthy females 18 – 40 years old reporting
no use of hormonal birth control and regular menstrual cycles of 28 d.
Based on self-report, participants also had no known past or present
neurological or psychiatric diagnoses (which would include premen-
strual dysphoric disorder), including no history of substance use dis-
orders, and no current use of psychoactive medications or other
psychoactive substances aside from moderate use of caffeine, nicotine, or
alcohol. All subjects were native English speakers and had at least a high-
school education. Participants gave written informed consent, as ap-
proved by the UNC Office of Human Research Ethics. Subjects
participated in two sessions, one on cycle days 1–2 (MP) and another on
cycle days 11–12 (FP), in a counterbalanced, within-subject design. The
menstrual cycle phase was based on participant self-report. All recruited
participants self-reported regular cycles of 28 d during study screening;
however, each participant’s cycle was not explicitly tracked across mul-
tiple cycles. We did not exclude women who experience symptoms of
premenstrual syndrome (PMS), although concerns on this point are
somewhat mitigated by the fact that PMS symptoms are present during
the luteal phase (LP), beginning 1–2 weeks before menses and completely
resolving at menses onset (Rubinow and Schmidt, 2006), and we did not
test women during the symptomatic phase of the cycle. In addition to the
behavioral testing (see Delay discounting task), during session 1 (n  45
MP, n  46 FP) we collected information on participants’ age, years of
education, trait impulsiveness [Barratt Impulsiveness Scale-11 (BIS);
Patton et al., 1995], orientation toward the future (Future Time Perspec-
tive Inventory; Wallace, 1956), and locus of control (Rotter’s Locus of
Control Scale; Rotter, 1966).
COMT genotyping. COMTVal158Met (rs4680) genotyping was per-
formed on DNA extracted from saliva samples (DNA Genotek) using
TaqMan technology (Life Technologies), as previously described (Boet-
tiger et al., 2007; Smith and Boettiger, 2012).
Delay discounting task. During each testing session, participants com-
pleted a DD task, which has been described in detail previously (Altami-
rano et al., 2011; Smith and Boettiger, 2012). Subjects were given task
instructions, completed a short practice, and then completed eight blocks
of 42 trials each during each test session. In each session, subjects made a
series of choices between smaller, sooner (“Now”) and larger, later
(“Later”) hypothetical monetary rewards. Each trial began with an in-
struction cue, followed by two options. In each trial, the Later option was
one of five amounts ($2, $5, $10, $20, or $100) at one of five future delays
(1 week, 2 weeks, 1 month, 3 months, or 6 months), and the Now option
was an amount discounted by 70, 85, 90, or 95% from the Later amount,
available “TODAY.” The instruction cue was determined by trial type.
There were four trial types: WANT, DONT WANT, SOONER, and
LARGER, with the latter two conditions considered together as control
(CON) trials. Accuracy in these control conditions verifies that individ-
uals are adhering to task instructions, while comparison of reaction times
(RTs) among the CON, WANT, and DONT WANT trial types indicates
whether additional cognitive processes are being engaged in the WANT
and DONT WANT conditions, relative to the simple objective compar-
ison needed for CON trials. A pattern of RTs that deviates from CON 
WANT  DONT WANT indicates that the task is not being performed
as instructed, and resulted in exclusion from all analyses (see below).
Trial types were pseudorandomly ordered and weighted, with one-half
WANT trials and one-sixth each of the other trial types. The WANT
condition was most frequent, as choice in that condition was our primary
interest here. Moreover, this weighting also promotes a prepotent ten-
dency to select the preferred option, requiring inhibition in the DONT
WANT condition. Participants indicated their preferred option on
WANT trials, their nonpreferred option on the DONT WANT trials,
and the side with the sooner time or larger amount of money for
SOONER and LARGER (CON) trials, respectively. The Later amount,
delay time, percentage discount, and left/right position were pseudoran-
domly selected for each trial. The RT for each response was also collected.
Four subjects were excluded from all analyses based on deviation from
the expected RT pattern across trial types (see above) in one or more
sessions, leaving 87 participants. Of these, 44 participants were first tested
in the MP, and 43 participants were first tested in the FP.
Our primary index of Now bias was the proportion of Now choices
made in the WANT condition, the impulsive choice ratio (ICR). From
the DONT WANT trials, we determined the inferred ICR (iICR) as a
function of delay time, and calculated the average of the absolute value of
the difference between ICR and iICR at each delay. This value provides a
measure of response consistency, termed “motor mismatch,” with larger
values indicating less controlled response selection (Mitchell et al., 2007).
Change in ICR from the MP to FP was calculated as a simple subtraction
of the ICR in the FP session from the ICR in the MP session.
In addition to ICR, we also quantified the degree of impulsive choice
using the q-exponential discount function based on Tsallis’ statistics
(Takahashi et al., 2008; Takahashi, 2009), as follows:




where D represents delay time, and kq and q are measures of impulsivity
and of inconsistency across delay times, respectively. To estimate kq and
q, we conducted nonlinear curve fitting with the Levenberg–Marquardt
algorithm implemented in MATLAB (MathWorks, Curve Fitting Tool-
box, Custom Equation option). Discounted Value was calculated as the
cumulative selected/maximum dollar ratio at each delay, D. In addition
to estimating kq and q, we can also quantify the degree to which impa-
tience declines as a function of delay time [decreasing impatience (DI)],
as proposed by Prelec (2004) and implemented within the q-exponential
discount function (Takahashi, 2011), as follows:
Dlq	D
  kq	1  q
/1  kq	1  q
D, (2)
where D, kq, and q are as defined for Equation 1. We excluded n  37
subjects from these analyses based on an inadequate fit by the
q-exponential model (defined as an adjusted R 2 value of 0.2 for one or
both sessions). For the subjects from whom we had E data, our sample
was reduced to n  10 and therefore was underpowered for any E
change analyses.
Salivary estradiol quantification. To confirm and quantify E changes
from the MP to the FP in our participants, we obtained permission to
collect saliva samples at each visit and were able to collect these data from
34 of our 87 participants. There were no significant differences between
the participants from whom we obtained salivary E measures and those
we did not, in terms of ICR ( p  0.61), demographics (minimum p 
0.46), or psychometric measures (minimum p  0.09). The use of sali-
vary E was based first on the noninvasive and less stressful nature of this
collection method (relative to serum collection). Given data showing
that cortisol, a physiological mediator of stress responses, can impact
discounting behavior (Takahashi, 2004; Takahashi et al., 2010; Kawa-
mura et al., 2013), avoiding the expected stress associated with an actual
or anticipated blood draw in some subjects, served to minimize un-
wanted variance in our data. Second, empirical data support the correla-
tion between salivary and serum E levels (Lu et al., 1999). Three saliva
samples were collected during each session from participants via passive
drool into 15 ml tubes over a period of 1 h while they completed
questionnaires and/or during task breaks. Samples were pooled and
stored at 20°C until analysis. Upon thawing, saliva samples were cen-
trifuged at 1500  g for 15 min to separate mucous material and pellet
out any potential contaminants. Cleared saliva was then decanted into a
separate tube. We quantified salivary estradiol via an enzyme immuno-
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assay kit (Salimetrics). On each plate, pooled samples were tested in
duplicate, with samples from both visits for each subject tested on the
same plate. Optical densities were measured using a Quant microplate
spectrophotometer (BioTek) and, following kit procedure, were trans-
formed into picogram per milliliter E values based on plate-specific
four-parameter sigmoid minus curves derived from standard E sam-
ples. E concentrations for each sample were averaged across plates.
Only individuals with higher average E levels in their FP sample than in
their MP sample were classified as showing a positive change in E
(E). The proportional change in E value used in our correlation
analyses reflect the difference in E between the FP and MP samples
divided by MP E (E  (FP E  MP E)/MP E).
Statistical analysis. As the ICR, kq, q, and DI data in this sample were
not normally distributed, the Wilcoxon signed-rank test was used for
comparisons across sessions. Paired t tests and repeated-measures ANO-
VAs were used to test for the effect of cycle phase on other DD task
measures as well as on arcsine-root transformed ICR values. Group com-
parisons of ICR change were made using unpaired t tests. Pearson’s r or
Spearman’s  were used for correlation analyses, as indicated. We used
bootstrapping where indicated to eliminate concerns about violations of
parametric assumptions, and 95% CIs are reported. Where sphericity
was violated, we applied the Greenhouse-Geisser correction.
Results
Sample characteristics
Eighty-seven healthy females from the Chapel Hill/Durham, NC,
area volunteered and were paid for their participation (Table 1).
In the sample as a whole, we observed a positive correlation (r(85) 
0.22; p  0.040) between Now bias measured in session 1 and the
nonplanning subscale of the BIS, a trait measure of impulsivity,
which is consistent with some previous findings (Mitchell et al.,
2005; de Wit et al., 2007).
Impulsive choice declines from early to mid-cycle
We predicted a decline in our measure of Now bias, ICR (see
Materials and Methods) from the MP to the FP, which was indeed
observed. Across the participant group as a whole, we found a
significant effect of cycle phase on ICR, with higher ICRs in the
MP (median, 0.72) relative to the FP (median, 0.66) using either
a Wilcoxon signed-rank test on the raw ICR values (z  2.77;
p  0.006; r  0.21), or a paired-samples t test on arcsine-root
transformed ICR data (t(86)  2.13; p  0.036; Fig. 1A). Although
we counterbalanced session order, we confirmed that this cycle
effect remained significant after covarying for session order in a
repeated-measures ANOVA (F(1,85)  4.65; p  0.034; 
2 
0.049).
This DD task includes objective choice CON trials; accuracy in
these trials did not differ significantly between the MP and FP
sessions (t(86)  0.66; p  0.51). The task also includes a control
condition (DONT WANT) in which participants are instructed
to select the monetary reward option that they do not prefer.
Comparing ICR in the WANT trials to inferred ICR in the
DONT WANT trials provides a measure of response consis-
tency. We observed a significant effect of cycle on response con-
sistency or motor mismatch (see Materials and Methods), with
greater mismatch in the FP (0.13  0.08) relative to the MP
(0.10  0.06; t(86)  2.63; p  0.010). Importantly, our ob-
served cycle effect on Now bias remained significant after cova-
rying for changes in response consistency in a repeated-measures
ANOVA (F(1,85)  6.02; p  0.016; 
2  0.066), indicating that a
drop in response consistency cannot explain the decrease in Now
bias at mid-cycle. We observed no cycle effects on RT in the
objective choice (CON) trials (t(86)  1.28; p  0.21), subjective
choice trials (WANT; t(86)  0.01; p  0.99), or DONT WANT
trials (t(86)  0.27; p  0.79).
As a measure of impulsive choice, ICR has several advantages.
First, it has very strong internal reliability. For the present dataset,
the Cronbach’s  for ICR ranged between 0.977 and 0.995 across
the various conditions, indicating an extremely high level of reli-
ability. Second, ICR is an assumption-free metric, rendering it
less sensitive to errors introduced by incorrect models. These
strengths are of particular importance when making compari-
sons across conditions, as in the present study. In contrast, dis-
counting rates (k) are derived via curve-fitting using discounting
models and depend strongly on both the assumptions of the par-
ticular model and on the variability of the underlying data from
which such fits are derived. Despite these caveats, recent studies
have demonstrated the utility of the q-exponential discount func-
tion in parameterizing both Now versus Later preference (impul-
sivity; kq) and the inconsistency (q) in such Now bias across delay
times in intertemporal choice tasks (Takahashi et al., 2008; Taka-
hashi, 2009). Consistent with our ICR-based results, we found
that kq decreased significantly in the FP, relative to the MP; in
contrast, we did not observe a significant change in q from






(n  43) t(85) , p
Age (years) 24  5
Education (years) 16  2
Psychometric measures
BIS total score 60.2  11.7 60.6  11.6 59.8  12.0 0.32, 0.75
BIS attention 16.4  4.1 16.6  4.1 16.3  4.2 0.35, 0.73
BIS motor 21.6  4.2 22.0  3.9 21.3  4.6 0.80, 0.43
BIS planning 22.2  5.4 22.1  5.4 22.3  5.5 0.20, 0.84
FTPI
Mean extension 6.9  5.2 7.2  6.0 6.7  4.3 0.46, 0.64
Maximum extension 23.7  18.2 25.6  20.7 21.7  15.3 0.98, 0.33







Values are reported as the mean  SD, unless otherwise indicated. FTPI, Future Time Perspective Inventory; LOC,


























Figure 1. Impatient choice declines from early to mid-cycle. A, Now bias declines from early
to mid-cycle. The plot depicts an index of Now bias, ICR, measured during the MP (cycle days
1–2) and the FP (cycle days 11–12) within subjects. ICR values were significantly reduced at
mid-cycle (FP) relative to the MP (*t(86)  2.13; p  0.036). B, Decreasing Impatience, DIq is
plotted as a function of delay time. DIq is elevated in the MP relative to the FP (F(1,49)  5.56;
p  0.022), and, while DIq declines as a function of delay in both the MP and FP, DIq declines
more steeply in the MP. Values reflect the mean  SEM.
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early-to mid-cycle (Wilcoxon sign-rank test: kq, p  0.032; q, p 
0.188; Table 2). Perhaps not surprisingly, given these findings, kq
was strongly correlated with ICR (Spearman’s   0.850; 95% CI,
0.759 – 0.909; p  0.001), while the correlation between ICR and
q was much weaker and in the opposite direction (Spearman’s
  0.274; 95% CI, 0.069 to 0.446; p  0.006). We also
quantified the time decay of the discount rate (kq) across delay
times using Prelec’s measure of decreasing impatience (DI)
(2004), as implemented within the q-exponential discount func-
tion by Takahashi (2011). A repeated-measures ANOVA (Cycle
Phase  Delay Time) found significant main effects of both Cycle
Phase (F(1,49)  5.56; p  0.022; 
2  0.015) and Delay Time
(F(1.02,50.09)  69.7; p  0.001; 
2  0.412), and a significant
interaction between Cycle Phase and Delay Time (F(1.02,50.14) 
4.33; p  0.042;  2  0.011; Fig. 1B). Average DIq across delay
times was higher in the MP (mean, 0.0229; 95% CI, 0.0183–
0.0277) versus the FP visit (mean, 0.0171; 95% CI, 0.0127–
0.0218; t(49)  2.36; p  0.022). We confirmed the effect of delay
time on DIq with a Friedman’s test on DIq change scores (FP 
MP) across delay times (	 2  11.52; p  0.021; df  4). Post hoc
paired comparisons of DIq at each delay time in the MP and FP
visits showed significant decreases in DIq from the MP to the FP at
all five delays (mean decreases, bootstrapped: 7 d, 0.0145, t 
2.15, p  0.036; 14 d, 0.0083, t  2.39, p  0.013; 30 d, 0.0043, t 
2.57, p  0.005; 90 d, 0.0015, t  2.57, p  0.012; 180 d, 0.0007,
t  2.43, p  0.017). These data indicate that the irrationality of
intertemporal choice declines from the MP to the FP, with the
greatest cycle effects at the shortest delay and diminishing cycle
effects with increasing delay times.
The mid-cycle drop in Now bias is associated with an E rise
While the decrease in Now bias from the MP to the FP is consis-
tent with a hypothetically E-mediated effect, hormonal fluctu-
ation across the cycle varies, even among women with regular
cycles. To more directly assess the relationship between changes
in E and changes in Now bias, we assayed salivary E from
both sessions from a subset of participants (n  34). On average,
E rose (0.50  0.23 pg/ml) from the MP to the FP (t(33) 
2.20; p  0.035). However, of the 34 participants, only 23 dem-
onstrated a detectable increase in E from the MP to the FP (E
rose 1.15  0.89 pg/ml; t(22)  6.20; p  0.001); critically, these
23 participants also showed a significant decrease in Now bias
(0.07  0.03) from the MP to the FP (t(22)  2.18; p  0.041;
Fig. 2). In contrast, in those participants without a detectable rise
in E (n  11; E decreased by 0.85  1.07 pg/ml; t(10)  2.62;
p  0.026) Now bias tended to rise from the MP to FP (0.05 
0.05; t(10)  1.09; p  0.303; Fig. 2). The cycle effect on Now bias
differed significantly between the E rise and the no-E rise
participants (t(32)  2.145; p  0.040; Fig. 2).
Changes in Now bias from the MP to FP are inversely related
to changes in E
As we observed substantial variation in E changes from the MP
to the FP, we tested whether the magnitude of the E change
between sessions was correlated with individual change in Now
bias. To avoid concerns about violating parametric assumptions,
we calculated the Spearman’s  between the proportional change
in E from the MP to the FP and the change in ICR from the MP
to the FP, and conducted a robust regression analysis procedure
using bootstrapping. We found a significant negative correlation
between E change and ICR change ((32)  0.39; 95% CI,
0.67 to 0.06; p  0.023; Fig. 3, solid line), suggesting a role for
E in mediating the observed cycle effects on Now bias.
Table 2. Estimated parameters in q exponential discounting by cycle phase
MP FP z score p value
kq (impulsivity) 0.002488 0.001242 2.148 0.032*
q (consistency) 20.6 13.91 1.318 0.188
Median parameter values are given by cycle phase. Smaller kq indicates less impulsive intertemporal choice at D 














Figure 2. Now bias declines at mid-cycle when E rises at mid-cycle. The plot depicts the
change in ICR from early to mid-cycle in participants with a verified rise in E levels at mid-
cycle (E rise), and those without a detectable rise in E levels at mid-cycle (No E rise). ICR
declines significantly at mid-cycle in the E rise group ( †t(22)  2.18; p  0.041). The
change in ICR from early to mid-cycle differed significantly between the E rise and no-E rise



















COMT     carrierVal
Met/Met
Figure 3. The change in ICR from early to mid-cycle is proportional to the change in E and
is driven by putatively lower tonic frontal dopamine COMT Val carriers. In the sample as a whole,
ICR decreases correlate with E increases (  0.39; p  0.023, solid line). This effect is
driven by COMT Val allele carriers (open circles; 0.58; p  0.003, dotted line). Changes in
E levels and ICR from MP to FP are not correlated in individuals with putatively high tonic
frontal dopamine levels (COMT Met/Met, filled circles;   0.12; p  0.75, dashed line).
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E in session 1 correlates with trait impulsivity
Based on our findings that session 1 ICR positively correlated
with BIS nonplanning scores, and that ICR fluctuated from the
MP to the FP in tandem with E changes, we tested whether E
levels in session 1 correlated with BIS nonplanning scores. We
found that, indeed, each additional picogram per milliliter of E
measured in session 1 was associated with 0.79 points lower BIS
nonplanning scores (r(32)  0.42; 95% CI, 0.63 to 0.20; p 
0.014). A similar relationship between session 1 E levels and
total BIS scores (r(32)  0.36; p  0.036) was also observed.
COMT genotype modulates E effects on Now bias
As the effects of E changes from the MP to FP on working
memory, which is also frontal DA dependent, are modulated by
the COMT Val158Met genotype (Jacobs and D’Esposito, 2011),
we tested whether the observed relationship between E eleva-
tion and reduced Now bias is also modulated by COMT geno-
type. Of the participants from whom we had E measures, the
distribution of COMT genotypes was as follows: 10 methionine
(Met)/Met, 9 Met/valine (Val), 15 Val/Val. Unlike the full sam-
ple, within the Met/Met group, we observed a statistically insig-
nificant increase in ICR with greater E rises ((8)  0.12;
p  0.75; 95% CI, 0.68 to 0.70; Fig. 3, dashed line). However, in
the Met/Val group, we observed a trend toward greater mid-cycle
declines in ICR with greater E rises ((7)  0.63; p  0.067;
95% CI, 1.0 to 0.24); Val homozygotes showed a similar nega-
tive relationship ((13)  0.29; p  0.302; 95% CI, 0.73 to
0.34). This similarity between the latter two groups is consistent
with data showing that Val carrier status predicts elevated impul-
sivity in females (Qian et al., 2003; Lang et al., 2007), and im-
paired executive function (Small et al., 2011) and hypothalamic-
pituitary-adrenal axis dysfunction (Fernández-de-Las-Peñas et
al., 2012) in female breast cancer survivors. As such, we consid-
ered Val allele carriers together and found significantly greater
mid-cycle declines in ICR with greater mid-cycle E rises among
COMT Val carriers ((22)  0.58; p  0.003; 95% CI, 0.78 to
0.22; Fig. 3, dotted line), indicating that Val carriers drove the
effect observed in the sample as a whole. Note that average E
levels did not differ significantly by COMT genotype in either the
MP (F(2,31)  0.91; p  0.412) or FP visit (F(2,31)  0.05; p 
0.952). However, there was a trend toward COMT genotype-
dependent effects on the difference in measured E levels between
the MP and FP visits (F(2,31)  3.05; p  0.062), reflecting the fact
that we observed the greatest rise in E among COMTMet/Met indi-
viduals (0.78  0.91, standardized values), with substantially
smaller average E rises in COMT Val/Met (0.31  0.41) and
COMT Val/Val (0.18  0.47) individuals. The difference in E rise
between the COMT Met/Met and COMT Val/Val groups approached
statistical significance (t(12.28)  1.97; p  0.072). Thus, the
apparently greater sensitivity of Now bias to changes in E levels
among COMT Val carriers cannot be attributed to differences in
baseline E levels or to a greater degree of E change among the
COMT Val carriers, who together had smaller increases in E
from the MP to the FP than COMT Met/Met individuals (0.22 
0.45; t(10.86)  1.87; p  0.088).
Measures of frontal DA neurotransmission decrease from ad-
olescence to adulthood (Wahlstrom et al., 2010), including a rise
in COMT expression with age (Tunbridge et al., 2007). More-
over, in our previous study (Smith and Boettiger, 2012) with a
mixed sample of males and females, we found that age interacts
with COMT genotype to predict Now bias. That study defined the
late adolescent and adult groups as ages 18 –21 and 22– 40 years,
respectively, based both on preliminary results from other studies
in our laboratory showing Now bias differences between these
two age groups, and a large-scale investigation of functional brain
maturation, indicating that brain maturation asymptotes at ap-
proximately age 22 years (Dosenbach et al., 2010). Thus, we also
conducted an exploratory examination of the correlation be-
tween E change and ICR change within COMT Val carriers sep-
arately within our previously defined age groups (ages 18 –21 vs
22– 40 years). We observed a substantially larger correlation
among 22- to 40-year-old COMT Val carriers ((9)  0.77; p 
0.005; 95% CI, 0.95 to 0.26), who have the lowest predicted
tonic PFC DA levels, relative to 18- to 21-year-old Val carriers
((11)  0.604; p  0.029; 95% CI, 0.93 to 0.09), consistent
with our inverted-U model (Smith and Boettiger, 2012). Within
the group with the highest predicted tonic PFC DA level (18- to
21-year-old Met/Met individuals), increasing E levels were as-
sociated with increased ICR at mid-cycle, although the effect was
not statistically significant ((2)  0.400; p  0.60). The relation-
ship between E change and ICR change was relatively flat in the
22- to 40-year-old Met/Met group ((4)  0.086; p  0.872).
While these observations are consistent with our hypothesized
results, these are highly preliminary findings, and it is partic-
ularly important to note that the tests within the Met/Met age
groups are grossly underpowered to detect even large effects.
Discussion
Here, we demonstrate that Now bias decreases significantly from
the MP to the FP. Participants with a verified rise in E levels
from the MP to the FP showed significantly greater decreases in
Now bias at mid-cycle than those without, with Now bias de-
creasing significantly in the E rise group but not in the no-E
rise group. The change in Now bias from the MP to the FP in-
versely correlated with the change in E, an effect driven by
individuals with putatively lower frontal DA levels. These data
suggest that the E rise during the peak fertility window modu-
lates Now bias through interactions with tonic frontal DA.
Neurocognitive effects of estrogen
Existing evidence links E and frontal-dependent function in
animals, presumably via E-induced enhancement of DA signal-
ing (Xiao and Becker, 1994; Pasqualini et al., 1995; Shansky et al.,
2004). E increases frontal dopaminergic innervation in pri-
mates (Kritzer and Kohama, 1999), increases frontal pyramidal
cell spine number (Tang et al., 2004), and affects frontal-
dependent task performance (Tinkler and Voytko, 2005; Hao et
al., 2007). Direct evidence for the relationship between E and
frontal DA levels in humans is lacking. PET studies suggest sex-
specific differences in DA D2 receptor levels (Kaasinen et al.,
2001); however, no published studies comparing the sexes have
used radiotracers suited to detect frontal DA levels. Furthermore,
there are no published human PET data regarding the effect of
cyclic E changes on DA signaling. However, behavioral and
fMRI data from humans indicate that E modulates frontal-
dependent cognitive processes (Keenan et al., 2001; Rosenberg
and Park, 2002; Colzato et al., 2010; Jacobs and D’Esposito, 2011;
Joseph et al., 2012). Moreover, E effects on working memory
interact with COMT genotype (Jacobs and D’Esposito, 2011).
Notably, time perception depends upon the frontoparietal cir-
cuits supporting working memory (Lewis and Miall, 2006; Piras
et al., 2014), and time perception has been shown to correlate
with delay discounting (Takahashi, 2004; Zauberman et al., 2009;
Han and Takahashi, 2012). Moreover, time perception has long
been known to be sensitive to DA (Meck, 1996), with DA in-
creases speeding up subjective time. More recently, acute E
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administration was also demonstrated to speed subjective time
perception in rats (Pleil et al., 2011). Thus, reduced Now bias at
mid-cycle could reflect accelerated subjective time perception
consequent to frontal circuit modulation by rising E levels.
However, elevated Now bias in the MP due to heightened re-
sponses to the more affectively salient proximate rewards during
low E cannot be ruled out (Goldstein et al., 2005). Further-
more, E actions in the hippocampus (Ooishi et al., 2012; Kato et
al., 2013), a structure linked to discounting behavior in both
rodents (Abela and Chudasama, 2014) and humans (Peters and
Büchel, 2010; Benoit et al., 2011), could also contribute to E
modulation of Now bias.
Dopamine as a potential mediator of the cycle effect on
decision making
The present data support the idea that E modulates Now bias
via the DA system, especially frontal DA. This conclusion derives
from the data described in the previous section coupled with our
finding that the correlation between changes in E and Now bias
from the MP to the FP varies with COMT Val158Met genotype.
The Val158Met polymorphism substitutes the ancestral Val for a
Met at position 158 in the COMT enzyme, resulting in a fourfold
reduction in enzyme activity (Chen et al., 2004). Reduced tonic
frontal DA is observed in people with the COMT 158 Val/Val geno-
type relative to COMT Met allele carriers (Wu et al., 2012). Ac-
cording to a model wherein Now bias varies with frontal DA
according to an inverted-U function (Mitchell et al., 2007; Alta-
mirano et al., 2011; Smith and Boettiger, 2012; Kelm and Boetti-
ger, 2013), these data suggest that E elevations alter Now bias
via interaction with frontal DA levels. This idea remains to be
empirically tested, but frontal-dependent tasks are generally sen-
sitive to frontal DA according to a quadratic function (Sawaguchi
and Goldman-Rakic, 1991; Vijayraghavan et al., 2007; Cools and
D’Esposito, 2011).
Role of other hormones in delay discounting
Other steroid hormones are implicated in the modulation of
Now bias. For example, salivary testosterone correlates with DD
among healthy male students (Takahashi et al., 2006). Delay dis-
counting has also been shown to negatively correlate with salivary
cortisol levels (Takahashi, 2004) and with a genetic polymor-
phism associated with increased plasma cortisol levels (Kawa-
mura et al., 2013). However, sex moderates the effect of salivary
cortisol: the relationship is negative among males, but positive
among females (Takahashi et al., 2010). It is worth noting that
stress (associated with elevated cortisol levels) impacts frontal
function in an inverted-U manner (Arnsten, 2009), with E ex-
acerbating stress-induced working memory impairment in ani-
mal models (Shansky et al., 2004, 2009). In humans, females are
more susceptible to stress-induced working memory impairment
than are men (Schoofs et al., 2013). To date, no studies have
investigated the effects of progesterone (PROG) on DD. More-
over, no study has yet examined multiple steroids, and this study
is the first to control for cycle phase in females. Future work
investigating the individual contributions of different steroid
hormones is needed for a complete picture of the hormonal mod-
ulation of Now bias. Perhaps most importantly, to date, no hor-
mone challenge studies have been conducted, which are required
to determine causal roles in modulating Now bias.
Other potential mediators of cycle effects on Now bias
Although our finding of COMT-dependent E effects on Now
bias suggests a mediating role for DA in the observed cycle effect
on Now bias, other neurochemical systems could be involved. In
particular, PROG or its neuroactive steroid (NAS) derivatives,
such as allopregnanolone (ALLO), which also rise across the cy-
cle, may contribute. Indeed, ALLO modulates cognitive function
in humans (Marx et al., 2009), possibly via positive modulation of
GABAA receptors (Majewska et al., 1986). Neuroimaging studies
have demonstrated that increases in PROG levels and decreases in
E levels from the FP to the LP result in changes in activity in a
host of PFC, limbic, and striatal regions (Dreher et al., 2007; van
Wingen et al., 2008; Ossewaarde et al., 2011; Marecková et al.,
2014). Like PROG and ALLO, GABA levels also rise from the FP
to LP (Epperson et al., 2002). Thus, PROG, ALLO, or GABA may
alter the function of neural circuitry implicated in Now bias, and
this requires further study. Imprecision in our sampling method
means that we cannot rule out a role for cyclic changes in PROG,
ALLO, or GABA in reducing Now bias at mid-cycle. Increased
GABAergic signaling could theoretically improve cognitive con-
trol, leading to reduced Now bias. Indeed, PROG administration
can improve cognitive control and reduce smoking urges (Sofuo-
glu et al., 2011). However, in women, ALLO impairs episodic
memory (Kask et al., 2008), which shares common neural sub-
strates with episodic prospection, a mental action that decreases
Now bias via increased frontotemporal connectivity (Peters
and Büchel, 2010; Benoit et al., 2011), which is weakened by
PROG increases (van Wingen et al., 2008). However, enhanc-
ing GABAA signaling reportedly has no effect on Now bias
(Reynolds et al., 2004; Acheson et al., 2006). Thus, although
the reduced Now bias we observed at mid-cycle could theoret-
ically reflect some contribution of PROG, a NAS, or GABA, no
direct data are available, and the circumstantial evidence does
not favor that interpretation.
Study limitations
Some study limitations prevent drawing strong conclusions re-
garding the role of specific hormones in the observed cycle effect
on Now bias. First, we assayed only E in our subjects, so roles
for other hormones cannot be ruled out. Second, we were not
able to collect E samples from all participants, although this
concern is somewhat mitigated by the fact that the subset provid-
ing E samples did not differ from the subset that did not. Con-
sidering the two subsets as independent samples, this fact could
be seen instead as a replication of our basic behavioral finding
across subsamples, strengthening that finding. Third, our
method relied on self-report of cycle day, and did not document
cycle duration or hormonal markers of ovulation across the cycle,
which could have substantially reduced variance, particularly in
the FP. We likely failed to catch the E peak in many partici-
pants, which could substantially diminish effect size. Indeed,
among the participants for whom we quantified E, many
showed little or no rise in E levels from the FP to the MP visit,
and the effect size was substantially greater in the participants for
whom we verified a rise in E levels in the FP. More precise
monitoring of hormone levels within individuals and targeting
behavioral measurements to individually determined cycle
phases are advised for future research. Moreover, while the re-
sults suggest a role for E in modulating Now bias, direct ma-
nipulation of E is required to establish a causal role.
Finally, while our finding that E interacts with a marker of
frontal DA tone is consistent with some existing literature, our
interpretation of those findings remains speculative. In particu-
lar, no direct evidence demonstrates that E modulates frontal
DA in humans, nor that frontal DA modulates Now bias accord-
ing to a U-shaped function. Future PET studies of DA signaling
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are needed to test our model. Regardless, our model suggests that
the effects of dopaminergic medications may be optimized by
taking E levels and COMT genotype into account. Given the
widespread use of such medications, such personalization could
have a broad therapeutic impact.
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